How the Brii–OpenBench deal could redefine early-stage drug discovery economics
Brii Biosciences Limited and OpenBench, Inc. have announced a strategic collaboration to integrate OpenBench’s structure-based artificial intelligence platform into Brii Biosciences’ discovery efforts. The partnership grants Brii Biosciences exclusive rights to novel lead compounds identified through OpenBench’s proprietary screening technology. The agreement includes an option to expand into additional programs, underscoring Brii Biosciences’ push into […]